Health Condition 1: null- Recurring episodes of Bacterial Vaginosis in women
Conditions
Interventions
Intervention1: Polyherbal Tablet Praneem/BASANT, WHO drugs metronidazole &
clindamycin and Probiotic lactobacillus tablet/gel: All women enrolled having AVDS will be treated for 14 consecutive days with Praneem Polyherbal tablets or Basant tablet or WHO drugs (such as metro
Sponsors
Department of Biotechnology
All India Institute of Medical Sciences, New Delhi
Sir Ganga Ram Hospital, New Delhi
Eligibility
Inclusion criteria
Inclusion criteria: 1.Women between age groups of 18-45 with regular cycles 2.Clinical history of chronic and/ or recurring episodes of abnormal vaginal dischargre. On pelvic examination,they are seen to have either excessive or unhealthy vaginal discharge. 3.Willing to participate in the study after having been explained about the nature of the body. Willing to return for follow up after 5-7 days of completion of treatment and thereafter on monthly basis for 3 months in part I of study.
Exclusion criteria
Exclusion criteria: 1.Known case of diabetes mellitus. 2. Suspected/confirmed pregnancy. 3.Suspected or known malignancy of reproductive tract 4.Less than 6 weeks since last delivery or abortion 5.H/O severe allergic reaction 6. Abnormalities of vaginal anatomy which will interfere with placement of drug 7. Known systemic diseases, immuno-compromised states 8. Adnexal mass or tenderness 9. Received a course of antibiotic therapy, less than 14 days prior to enrollment 10. Dysfunction uterine bleeding 11.Vaginal polyp
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Relief from Bacterial Vaginosis judged on the basis of Pelvic examination, pH and Nugent scoreTimepoint: 14 days | — |
Secondary
| Measure | Time frame |
|---|---|
| Colonization of Probiotic lactobacillus judged on the basis of Pelvic examination, pH and Nugent score.Timepoint: 3 months | — |
Countries
India
Contacts
Public ContactProf. G. P. Talwar
The Talwar Research Foundation, Delhi
Outcome results
None listed